Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to G Danta.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.